AMZN three-lens brief
Evidence-based stock research on AMZN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Negative free cash flow last quarterly (-$34.73B).
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Analyst mean target $326.99 — 23% above current (59 analysts).
- Negative free cash flow last quarterly (-$34.73B).
- Reported earnings on 2026-10-29.
AMZN closed at $266.17 (-1.74%) as of 2026-11-12. Market cap: $2.88T. P/E (trailing) 21.5. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; analyst mean target $326.99 — 23% above current (59 analysts).. Concerns: negative free cash flow last quarterly (-$34.73B).. Last quarter: Revenue $201.94B, net income $20.68B, free cash flow -$34.73B.
Why three lenses on AMZN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMZN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AMZN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMZN brief"></iframe>